Drug
Nebilet
Nebilet: highest development phase Phase 3, developed by Menarini. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Menarini
Trials
| Drug | Phase | Indication |
|---|---|---|
| Nebilet NCT00942487 | Phase 3 | Primary Arterial Hypertension |
Latest
No recent events.
Follow Nebilet on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.